Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas

NCT02456324 is registered in ClinicalTrials.gov with Curaseal Inc. as lead sponsor.

NCT NCT02456324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02456324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas
Lead sponsor
Curaseal Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2015
Completion date
August 31, 2016
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal fistulas, rectal fistulas